Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • Eleven Minutes
    • Priced Out
    • Data Grab
    • Memory Gaps
    • Growing Up Scared
    • Denied
    • Opioid Settlement Tracking
    • Guns, Race, and Profit
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email
  • Add Us to Google

Thursday, Nov 19 2026 8:45 AM

Full Issue

Research Roundup: The Latest Science, Discoveries, And Breakthroughs

Each week, KFF Health News compiles a selection of health policy studies and briefs.

The Washington Post: A New Thumb Implant Promises Improved Function For People With Arthritis 

For advanced arthritis, the most common treatment is a trapeziectomy. This involves removing the trapezium, a small bone at the base of your thumb, near your wrist. While it tends to be overall effective, it comes with some cons, too. A new medical device that was approved in 2025 is giving hand surgeons an alternative way to fix thumb arthritis that could cut recovery time and improve function. (Carter, 11/15)

MedPage Today: FDA OKs Drug Linked To Longer Survival In Fatal Genetic Disorder 

The FDA approved adrabetadex (Lembaz) injection on Tuesday for patients with infantile-onset Niemann-Pick disease type C (NPC), a rare and fatal genetic disorder. (Monaco, 11/18)

CIDRAP: People With Certain Herpes Infections Have Almost 50% Higher Risk Of Alzheimer’s Or Dementia, Review Finds

Being infected with herpes simplex virus type 1 (HSV-1) is associated with a 48% increase in the risk of Alzheimer’s disease or other types of dementia, according to a meta-analysis published this week in Open Forum Infectious Diseases. About two-thirds of people in the world under 50 are infected with HSV-1, which can cause cold sores and genital blisters. (Szabo, 11/17)

MedPage Today: Wegovy Reduces BMI In Kids With Obesity As Young As 6 

Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. (Monaco, 11/16)

MedPage Today: How Impactful Is Stock Epinephrine For Anaphylaxis At Schools?

A survey of school nurses suggests failure with relying on students to carry autoinjectors. But stock epinephrine doesn't help if there are no school nurses or they don't feel comfortable administering it, one expert said. (Phend, 11/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, November 19
  • Wednesday, November 18
  • Tuesday, November 17
  • Monday, November 16
  • Friday, November 13
  • Thursday, November 12
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF